Answers are grounded in this paper and cite their sources.
Observational analysis demonstrates downregulation of SHMT1 correlates with tumor stage in laryngeal squamous cell carcinoma, suggesting its role as a prognostic biomarker.
This study presents a validated prognostic risk score model comprising AAMRGs in LSCC. Furthermore, our findings highlight the downregulation of SHMT1 in LSCC and its significant association with patient prognosis and tumor stage.
No takes yet. Share an insight, caveat, or question.
Di et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: